NFKBIE and leukemia: To investigate how NFKBIE-mutations affect leukemia cell growth, we disrupted by CRISPR/Cas9 editing the NFKBIE gene in the murine TCL1-355-TKO cell line, which we recently established from the transgenic Eμ-TCL1 CLL model [19].